132 web-programmer-developer-"https:"-"https:" Postdoctoral positions at University of Oxford
Sort by
Refine Your Search
-
develop new research avenues and methodology. This full-time fixed-term post is funded by the MRC up to 31st March 2027 in the first instance. The actual starting salary offered will be based
-
mechanisms by which FAT protocadherins contribute to chromosomal instability and eventually shape cancer evolution. We are seeking a highly motivated and ambitious Postdoctoral Researcher to join our team
-
and manipulation and a knowledge of relevant statistical methods. You will possess exceptional organisational skills, an ability to work efficiently with collaborators and to supervise and educate
-
University of Oxford. The Centre aims to develop the first therapies to stimulate heart repair and regeneration in patients with heart failure, for which there are currently no effective treatments. REACT is a
-
12 months. The project involves developing nanopore sensing technologies for functional biomolecules and is funded by Bill and Melinda Gates Foundation. Find out more about the research and group
-
organisational skills that might include, sample management, electronic lab books, working with collaborators. Ability to work supportively in a laboratory environment, and to supervise and educate junior co
-
with the possibility of renewal. This project addresses the high computational and energy costs of Large Language Models (LLMs) by developing more efficient training and inference methods, particularly
-
, defensive mechanisms and related topics to the safe deployment of systems contain multiple LLM and VLM powered models. You will be responsible for Developing and implementing; capability evaluations, attacks
-
on the electrosolvation force under development in the group. The planned investigations are primarily experimental in nature, but will proceed in close conjunction with insight from theory and simulations. The ideal
-
precancers and developing targeted interventions, including vaccines, to intercept them. The project focuses on designing, validating, and preclinically testing neoepitope-based mRNA vaccines to prevent BRCA